microalbuminuria


Also found in: Dictionary, Acronyms, Wikipedia.
Related to microalbuminuria: macroalbuminuria

microalbuminuria

 [mi″kro-al-bu″min-u´re-ah]
an increase in urinary albumin excretion too subtle to be measured by conventional means, often seen with the hyperfiltration of diabetes mellitus.

mi·cro·al·bu·min·u·ri·a

(mī'krō-al-byū'min-yū'rē-ă),
A slight increase in urinary albumin excretion that can be detected using immunoassays but not using conventional urine protein measurements; an early marker for renal disease in patients with diabetes.
[micro- + albuminuria]

microalbuminuria

/mi·cro·al·bu·min·uria/ (-al-bu-min-u´re-ah) a very small increase in urinary albumin.

microalbuminuria

[mī′krō·al′bo̅o̅minoo͡r′ē·ə]
the urinary excretion of small amounts of albumin, below the detection level of routine dipstick analysis. The condition is an early indicator of altered glomerular permeability in diabetes.

microalbuminuria

The excretion of 30–300 mg albumin/day. An increase in albumin excretion predicts haemodynamic and morphologic changes of diabetic nephropathy. When increased, it is an early indicator of renal failure; the risk of microalbuminuria in diabetics increases when HbA1 value rises > 10%. Microalbuminuria is not invariably associated with renal failure and, in some patients, may regress.

microalbuminuria

Nephrology The excretion of 30-300 mg albumin/day; ↑ albumin excretion predicts hemodynamic and morphologic changes of diabetic nephropathy; when ↑, is an early indicator of renal failure the risk of microalbuminuria in DM ↑ when HbA1 value rises > 10%. See Diabetic nephropathy.

mi·cro·al·bu·mi·nu·ria

(mī'krō-al-bū'min-yūr'ē-ă)
A slight increase in urinary albumin excretion that can be detected using immunoassays but not by means of conventional urineprotein measurements; an early marker for renal disease in patients with diabetes.

microalbuminuria

The presence of almost undetectable traces of the protein albumin in the urine.

microalbuminuria

persistent excretion of small amounts of protein (<500mg in 24 hours) in urine due to incipient nephropathy; earliest presentation of kidney failure of diabetic nephropathy

mi·cro·al·bu·mi·nu·ria

(mī'krō-al-bū'min-yūr'ē-ă)
A slight increase in urinary albumin excretion that can be detected using immunoassays but not by means of conventional urine protein measurements; an early marker for renal disease in patients with diabetes.
[micro- + albuminuria]

microalbuminuria

(mī´krōalbyoo´mənur´ēə),
n a type of albuminaria that is characterized by relatively low levels of albumin in the urine (between 30 and 300 mg in 1 day). The increase in albumin secretion is generally too small to be detected by a conventional dipstick test but can indicate the beginnings of kidney disorders, especially those related to diabetes.
References in periodicals archive ?
7), (17), (18) In a follow-up to the Steno-2 study, 160 patients with T2DM and persistent microalbuminuria who had been randomized to receive intensive or conventional therapy for a mean of 7.
Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
2007) also showed that prevalence of microalbuminuria tended to decrease after six months of aerobic exercise in type 2 diabetic patients.
Type 1 Type 2 Microalbuminuria + + Sex M > F M > F Chronic + + Hyperglycaemia Advanced + + Glycation End Products Arterial +/- - Hypertension Smoking + ?
25, 44, 45) In a 6-month study (44) of hypertensive patients with type 2 diabetes and microalbuminuria, the combination of benazepril and amlodipine produced greater reductions in urinary albumin excretion than with benazepril monotherapy.
Conclusion: The results of our study concluded that level of serum uric acid and microalbuminuria are significantly correlated to nephropathy in patients having Type-2 diabetes mellitus.
Micral II test strips provide a screening test for microalbuminuria rather than providing a quantitative detection of microalbumin in urine.
A 2011 meta-analysis of 5 RCTs (total 2975 patients) that compared ACE inhibitor therapy with placebo in diabetic patients without hypertension and albuminuria found that ACE inhibitors reduced the risk of new-onset microalbuminuria or macroalbuminuria by 18% (relative risk [RR]=0.
Conclusion: The levels of CRP are higher in diabetics as compared to normal healthy controls and there is a progressive increase in the levels of CRP with increase in microalbuminuria in type 2 diabetics.
Increased urinary excretion of protein in patients with type 1 diabetes is indicative of the development of diabetic nephropathy; whereas, microalbuminuria as well as hypertension is already present at the time of diagnosis of diabetes in most patients with type 2 diabetes.
These hemodynamic abnormalities are associated with a higher prevalence of subclinical damage in various organs, deranged renal function related to microalbuminuria, and increased risks of cardiovascular events and mortality [3, 4].